Samsara BioCapital
Startup rounds since 2014 with a Samsara BioCapital investor on the board, and the firm's own fund filings.
Raises
20
since 2014
Unannounced
1
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Abcuro, Inc.$39.4M
- Claris Biotherapeutics, Inc.$55.7M
- Delfi Diagnostics, Inc.$34.3M
- Abcuro, Inc.$80M
- OrsoBio, Inc.$40M
- Alumis Inc.$129M
- OrsoBio, Inc.$84.6M
- Delfi Diagnostics, Inc.$225M
- Mineralys Therapeutics, Inc.$118M
- Syros Pharmaceuticals, Inc.$90.5M
- Chinook Therapeutics U.S., Inc.$115M
- Levo Therapeutics, Inc.$40M
- Levo Therapeutics, Inc.$46.5M
- Nkarta, Inc.$43.9M
- Principia Biopharma Inc.$50M
- Sutro Biopharma Inc$85.4M
- Syros Pharmaceuticals, Inc.$11.4M
- Principia Biopharma Inc.$15.3M
- Versartis, Inc.$55M
- Versartis, Inc.$10M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 0 |
| 2025 | 2 | 1 |
| 2024 | 2 | — |
| 2023 | 1 | — |
| 2022 | 2 | — |
| 2020 | 2 | — |
| 2019 | 3 | — |
| 2018 | 3 | — |
| 2015 | 1 | — |
| 2014 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Samsara BioCapital, L.P. | 31 Dec 2020 | $500M | — |
| Samsara BioCapital, L.P. | 20 Apr 2018 | $310M | $310M |
Listed because a Samsara BioCapital fund's filing names a director of each company. A name match is not a verified identity.